Life Sciences Tools and Services
Company Overview of SeraCare Life Sciences, Inc.
SeraCare Life Sciences, Inc. provides products and services to facilitate the discovery, development, and production of human and animal diagnostics, and therapeutics. The company’s Diagnostic and Biopharmaceutical Products segment offers controls and panels for the evaluation and quality control of infectious disease tests in clinical laboratories, blood banks, and in vitro diagnostic (IVD) manufacturing; and reagents and bioprocessing products for use in the discovery, development and manufacturing processes for drugs, vaccines, and diagnostic tests. It also provides diagnostic intermediates for use in manufacturing diagnostic test kits; cell culture additives and media that maintain viabi...
37 Birch Street
Milford, MA 01757
Founded in 1984
Key Executives for SeraCare Life Sciences, Inc.
Chief Executive Officer and President
Chief Financial Officer and Secretary
Vice President of Human Resources
Vice President of Manufacturing Operations
Compensation as of Fiscal Year 2013.
SeraCare Life Sciences, Inc. Key Developments
Seracare Life Sciences Introduces IVD Labeled ACCURUN Controls for Women's Health
Nov 12 13
SeraCare Life Sciences announced availability of IVD labeled ACCURUN(R) controls for Women's Health. These Human Papilloma Virus (HPV) and Chlamydia trachomatis/Neisseria gonorrhea (Ct/Ng) offerings are cellular-based independent controls used by clinical laboratories to challenge their in vitro diagnostic assays. ACCURUN 372 HPV DNA positive controls challenge HPV tests from extraction through amplification and detection. They are cellular-based controls formulated for use with laboratory tests that detect HPV DNA in human cervical samples. ACCURUN 341 Ct/Ng controls closely mimic human samples due to whole organism structure and deliver convenient plug and play design for direct placement on the instrument.
SeraCare Life Sciences Expands R&D Facilities
Sep 20 13
SeraCare Life Sciences announced an expansion of its research and manufacturing facilities at its Milford, Massachusetts headquarters. The addition of the facility was driven by new companion diagnostic manufacturing opportunities with key diagnostic partners and enhances the company's ability to manufacture innovative molecular diagnostic kits and components used in vitro diagnostics and companion diagnostics under stringent design control and quality systems. Under this initiative, SeraCare is adding 5,000 square feet of space to its Milford research and manufacturing building. This facility will include an ISO 8 classified clean room, four advanced molecular laboratories and a sophisticated air handling and purifying system. The new laboratories will also feature polymerase chain reaction capabilities, amplicon segregation process design and sequencing instrumentation to aid in the development of molecular diagnostic kits and components.
SeraCare Life Sciences, Inc. Introduces New AccuSet anti-Toxoplasma Performance Panel
Jul 22 13
SeraCare Life Sciences, Inc. has introduced a new AccuSet anti-Toxoplasma performance panel. This is the newest addition to the SeraCare line of performance panels designed to help In vitro diagnostic, or IVD, manufacturers effectively challenge new assays during development. Screening for the Toxoplasma gondii parasite is performed widely in pregnant women, infants born to infected women, and people with severely weakened or compromised immune systems, creating strong demand for rigorous anti-Toxoplasma assays. SeraCare's new AccuSet Anti-Toxoplasma gondii Mixed Titer Performance Panel (PTT202) helps IVD manufacturers respond to this market need. It comprises 21 members with a broad range of reactivity for IgG and IgM antibodies and contains donor material representing newer infections, which is critical for IVD manufacturers to effectively challenge new assays.
Similar Private Companies By Industry
Recent Private Companies Transactions